iiinova — where your digital self keeps evolving

Shubharthi Kar @karnephro.bsky.social · 03/12/2025

Happy to share that our abstract has been accepted for upcoming #ISNWCN

Shubharthi Kar @karnephro.bsky.social · 23/11/2025

My conference talk at the Kidney Foundation Dhaka, Bangladesh, concluded with an invitation to register for the upcoming WCN 2026, to be held from March 28–31 in Yokohama, Japan. 🐦‍⬛ Please note that the deadline for Early Bird Registration is January 24, 2026. #ISNWCN #ThisisISN

010

Shubharthi Kar @karnephro.bsky.social · 30/06/2025

⚡️Let’s have a closer look at the associations of each of these antigens #ECNeph @arvindcanchi.bsky.social indianjnephrol.org/an-updated-r...

142

Shubharthi Kar @karnephro.bsky.social · 30/06/2025

⚡️PLA2R antibody seropositivity doesn’t mean that we do not investigate for underlying malignancies. Here is a Case Report showing PLA2rAb MN having Carcinoma Oesophagus #ECNeph @theisn.org @myadla.bsky.social @dramiliflores.bsky.social @arvindcanchi.bsky.social

041

Shubharthi Kar @karnephro.bsky.social · 30/06/2025

KDIGO recommends Population and Age-appropriate Screening for malignancies irrespective of antigen status #ECNeph @theisn.org @myadla.bsky.social @dramiliflores.bsky.social @arvindcanchi.bsky.social

051

Shubharthi Kar @karnephro.bsky.social · 30/06/2025

3 approaches Contd 2. Panel approach: Alternatively, a laboratory could employ a standard panel of antibodies for antigens that can vary depending on volume and demographics 3. Proteomic approach: Laser microdissection of MN glomeruli, followed by mass spectrometry. #ECneph

010

Shubharthi Kar @karnephro.bsky.social · 30/06/2025

3 approaches suggested by the Mayo clinic consensus report 1. Targeted approach: Perform antigen testing based on clinical disease association Cont #ECNeph www.kidney-international.org/article/S008...

120

Shubharthi Kar @karnephro.bsky.social · 30/06/2025

Here’s a timeline of the auto-antigens found in MN #ECNeph @theisn.org @myadla.bsky.social @dramiliflores.bsky.social @arvindcanchi.bsky.social indianjnephrol.org/an-updated-r...

020

Shubharthi Kar @karnephro.bsky.social · 30/06/2025

Different types of tumor secrete different types of antigen. Here is the proposed mechanism of malignancy associated MN. #ECneph @dramiliflores.bsky.social @myadla.bsky.social @theisn.org www.frontiersin.org/journals/med...

031

Shubharthi Kar @karnephro.bsky.social · 30/06/2025

🫣 So, let us now reveal the diagnosis. It is malignancy associated Membranous Nephropathy 👉 The association between malignancy and MN was first described in 1968 ⚡️They also gave the 4 stages of MN #ECNeph @theisn.org @myadla.bsky.social @dramiliflores.bsky.social @arvindcanchi.bsky.social

130

Shubharthi Kar @karnephro.bsky.social · 30/06/2025

Hello Shubharthi ,From Sylhet, Bangladesh .Thank you @theisn.org for selecting our case from #Bangladesh No COI #ECneph

121

Shubharthi Kar @karnephro.bsky.social · 29/05/2025

When you must do a CKD screening while your patient planning for pregnancy? This slide is from today's ISN-KDIGO Webinar

021

Shubharthi Kar @karnephro.bsky.social · 14/05/2025

My Meeting with Md Mohiuddin Al Helal, Senior Assistant Secretary ,Ministry of Health and Family Welfare,Bangladesh on Guatemala resolution. He is one of the team member who will be attending #WHA78 representing Bangladesh. #ThisisISN

121

Shubharthi Kar @karnephro.bsky.social · 25/04/2025

2/3But things have changed now -both the Incidence and Death rates from Malaria decreased in #Bangladesh It achives significant development in #Malaria control. It is a huge success story achieved by

110

Shubharthi Kar @karnephro.bsky.social · 18/04/2025

New KDIGO guideline for NS children has been published

010

Shubharthi Kar @karnephro.bsky.social · 24/01/2025

🌍 In a time of global donor shortages, Dr. Riella’s groundbreaking xenotransplantation efforts bring new hope to kidney patients and nephrologists. 📅 Date: 07 February ⏰ Time: 02:15 PM Join #ISNWCN for a session on this novel and transformative topic in nephrology! @theisn.org

021

Shubharthi Kar @karnephro.bsky.social · 13/01/2025

It will be exciting to meet the @onconephrology leaders in person, listen to their insights, and ask them questions. I am always grateful to @kdjhaveri for publishing his book on #onconephrology, which I highly recommend to my colleagues. #ISNWCN

131

Shubharthi Kar @karnephro.bsky.social · 13/01/2025

The past decade has been incredible in the field of oncology, with the emergence of innovative molecules.These advancements also bring considerations regarding their interactions with kidney function. #ISNWCN has organised session on this fascinating topic

122

Shubharthi Kar @karnephro.bsky.social · 10/01/2025

Kidney doctors need to be advocates for kidney health. Advocacy is needed worldwide because kidney patients face challenges everywhere. If you are passionate about advocacy, we invite you to join this session. #ISNWCN #nephsky

031

Shubharthi Kar @karnephro.bsky.social · 30/12/2024

We need to become more familiar with #POCUS relatively newer diagnostic modality #ISNWCN going to be a great opportunity to learn it .

053